ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå : ¼­ºñ½º À¯Çüº°, ȯÀÚ À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°
Medical Accompaniment Service Market, By Service Type, By Patient Type, By End User, By Geography
»óǰÄÚµå : 1671854
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,156,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,576,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,681,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀåÀº 2025³â¿¡´Â 4,860¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â¿¡´Â 8,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â ¿¬Æò±Õ 7.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 4,860¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR: 7.60% 2032³â °¡Ä¡ ¿¹Ãø 8,120¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå Á¡À¯À²(%)
Medical Accompaniment Service Market-IMG1

¼¼°è ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀåÀº ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¿Í Àå±âÀûÀÎ ÀÇ·á ¼­ºñ½º¸¦ ÇÊ¿ä·Î Çϴ ȯÀÚ Áö¿ø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÃÖ±Ù ¼ö³â°£ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ç¾ú½À´Ï´Ù. ÀÇ·á µ¿Çà ¼­ºñ½º´Â ³»ºñ°ÔÀ̼Ç, ¹ø¿ª, À̵¿, µ¿Çà ¹× ±âŸ ºñÀÓ»ó ¼­ºñ½º·Î ȯÀÚ¸¦ Áö¿øÇÏ¿© ȯÀÚ°¡ ÃÖÀûÀÇ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. »ýȰ½À°üº´°ú ³ëÈ­ °ü·Ã Áúº´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ä¡·á ¹× ȸº¹ °úÁ¤ÀÇ ¹°·ù¸¦ °£¼ÒÈ­Çϰí Á¤½ÅÀû ÁöÁö¸¦ º¸ÀåÇϱâ À§ÇØ ÀÌ·¯ÇÑ º¸Á¶ ¼­ºñ½º¸¦ ¼±ÅÃÇϴ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, ´Ü¼øÇÑ ÀÓ»ó Ä¡·áº¸´Ù ÀüÀÎÀû °Ç°­¿¡ ´ëÇÑ °ü½É Áõ°¡, °£º´ÀÎ ºÎÁ· µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í ¹ý±ÔÁؼö ¹®Á¦°¡ °úÁ¦·Î ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ±àÁ¤ÀûÀÎ Ãø¸é¿¡¼­´Â ÀÇ·á°ü±¤ÀÇ ±Þ¼ÓÇÑ È®´ë¿Í ¸ÂÃãÇü ÀÇ·á Çõ¸íÀÌ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ Áö¹æ¿¡¼­ÀÇ ¼­ºñ½º Á¶Á¤ ¹× Á¢±Ù¼º Çâ»óÀ» À§ÇÑ Ã·´Ü µðÁöÅÐ ¼Ö·ç¼ÇÀÇ ÅëÇÕÀº ÇâÈÄ ½ÃÀå È®´ë¸¦ ´õ¿í °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½Å±Ô ¼­ºñ½º ¹ßÇ¥ ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, ¼­ºñ½º Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷¿¡´Â GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., BioNTech SE µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ ¼­ºñ½º Ãâ½Ã, È®Àå, Á¦ÈÞ, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå º¸°í¼­´Â ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ, ÀÇ·á ±â°ü, ÁöºÒÀÚ, ±ÔÁ¦ ´ç±¹, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº º» Á¶»ç¿¡¼­ Á¦°øÇÏ´Â ´Ù¾çÇÑ ½ÃÀå µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå, ¼­ºñ½º À¯Çüº°, 2020-2032³â, (100¸¸ ´Þ·¯)

Á¦5Àå ¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå, ȯÀÚ À¯Çüº°, 2020-2032³â, (100¸¸ ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2032³â, (100¸¸ ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ÀÇ·á µ¿Çà ¼­ºñ½º ½ÃÀå, Áö¿ªº°, 2020-2032³â, °¡Ä¡(100¸¸ ´Þ·¯)

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¾Ö³Î¸®½ºÆ®ÀÇ ±ÇÀå»çÇ×

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Accompaniment Service Market is estimated to be valued at US$ 48.6 Mn in 2025 and is expected to reach US$ 81.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: US$ 48.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.60% 2032 Value Projection: US$ 81.2 Mn
Figure. Medical Accompaniment Service Market Share (%), By Region 2025
Medical Accompaniment Service Market - IMG1

The global medical accompaniment service market has been witnessing significant growth in the recent past owing to the rising demand for quality healthcare services and support for patients requiring long-term medical care. Medical accompaniment services help patients in navigation, translation, transportation, companionship, and other non-clinical services allowing them to receive optimal care. As lifestyle diseases and age-related illnesses are on the rise, more patients are opting for these supplementary services to simplify logistics and ensure emotional support during their treatment or recovery process.

Market Dynamics:

The primary growth drivers for the medical accompaniment service market include growing geriatric population base susceptible to chronic diseases, increasing preference for holistic wellness over mere clinical treatment, and shortage of caretakers. However, data privacy concerns and legal compliance issues pose challenges. On the positive side, rapid medical tourism expansion and personalized healthcare revolution are opening lucrative opportunities. Moreover, integration of advanced digital solutions for service coordination and improved access in rural regions can further accelerate the market expansion going forward.

Key Features of the Study:

This report provides in-depth analysis of the global medical accompaniment service market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new service launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global medical accompaniment service market based on the following parameters - company highlights, service portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., and BioNTech SE

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future service launches, expansions, collaborations and marketing tactics

The global medical accompaniment service market report caters to various stakeholders in this industry including service providers, healthcare organizations, payers, regulators and new entrants

Stakeholders would have ease in decision-making through various market data analyses provided in the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Medical Accompaniment Service Market, By Service Type, 2020-2032, (USD Mn)

5. Global Medical Accompaniment Service Market, By Patient Type, 2020-2032, (USD Mn)

6. Global Medical Accompaniment Service Market, By End User, 2020-2032, (USD Mn)

7. Global Medical Accompaniment Service Market, By Region, 2020 - 2032, Value (USD Mn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â